NAD

NAD Recommends Alcon Vision Discontinue Certain Challenged Claims in Professional Advertising for Intraocular Lenses, Finds Certain Claims Supported

NAD recommended that Alcon Vision, LLC discontinue certain challenged claims in professional advertising for its AcrySof IQ ReSTOR +2.5 D and +3.0 D Multifocal Intraocular Lenses, following a challenge by Johnson & Johnson Surgical Vision, Inc. (“JJSV”), maker of competing TECNIS Symfony intraocular lenses. Intraocular lenses (“IOLs”) are implantable medical devices that surgeons use to replace patients’ natural lenses after they are removed during cataract surgery.

Read More

NAD Recommends Molekule Discontinue Pollution Elimination, Asthma and Allergy Symptom Relief Claims for its Molekule Home One Air Purifier; Advertiser to Appeal Certain Findings

NAD has recommended that Molekule Inc. discontinue its pollution, bioaerosol and VOC elimination/destruction claims (both quantified and otherwise), performance claims concerning its MH1 Air Purifier (MH1), its comparative superiority claims versus air purifiers that contain HEPA filters, and its allergy and asthma symptom relief claims, following a challenge by Dyson, Inc., maker of competing air purifiers. The advertiser has said it will appeal certain NAD findings and recommendations to the NARB but will comply with other recommendations.

Read More

Kimberly-Clark Corporation Discontinues “Wet to Dry in 10 Seconds” (Or Less) Claim for Huggies Snug & Dry Diapers

Kimberly-Clark Corporation stated that it will permanently discontinue the challenged express claim “Wet to Dry in 10 Seconds” (or less) (*time to absorb 50 ml of fluid below the liner) in online advertising and on packaging for its Huggies Snug & Dry Diapers, following a challenge before NAD by P&G, maker of Pampers Diapers.

Read More

NAD Recommends Bayer Discontinue Comparative Superiority Claims for Aleve Following Johnson & Johnson Challenge; Advertiser to Appeal

NAD has recommended that Bayer Healthcare LLC discontinue the claims “Proven Better on Pain than Tylenol Extra Strength” and “Proven Better on Pain than Tylenol,” following a challenge by Johnson & Johnson Consumer Inc., maker of Tylenol products. The advertiser has said it will appeal NAD’s findings to NARB.

Read More

NAD Finds NFL’s Claims Regarding AT&T’s Discontinuance of the NFL Network on its DIRECTV NOW and U-Verse Platforms are Supported

NAD has concluded that NFL Enterprises LLC provided a reasonable basis for the challenged express claims that AT&T decided to discontinue carrying the NFL Network on its DIRECTV NOW and U-verse platforms. The claims were challenged by AT&T Services, Inc. and DIRECTV, LLC (collectively AT&T) and appeared in an integrated marketing campaign consisting of emails, a website, and television advertising.

Read More

NAD Finds Cox Communications’ Reliability Claims for its Cable Television Service Supported, Following Challenge by AT&T

NAD has found that Cox Communications, Inc.’s television commercial comparing its cable television service to DIRECTV service does not reasonably convey the challenged implied claim that “DIRECTV does not work in bad weather and is highly unreliable,” and determined that the express claims therein are supported. Cox’s commercial was challenged by AT&T Services, Inc., provider of the competing DIRECTV satellite television service.

Read More